Neurophysin binding of vasopressin analogues altered at the NH 2 - and COOH-terminal positions
Kluh, I.; Sedláková, E.; Barth, T.; Cort, J.H.
Molecular Pharmacology 9(3): 414-420
1973
ISSN/ISBN: 0026-895X PMID: 4710138 Document Number: 62034
Document emailed within 1 workday
Related Documents
Schmale, H.; Heinsohn, S.; Richter, D. 1983: Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor EMBO Journal 2(5): 763-767Thomas, D.W.; Solvay, M.J.; Irani, D.N.; Nairn, R. 1985: Importance of the COOH terminal of angiotensin in antigenicity and in the formation of an antigen-containing complex with cellular membrane structures Journal of Immunology 135(6): 4086-4089
Sakaguchi, K.; Kodama, H.; Matsumoto, H.; Yoshida, M.; Takano, Y.; Kamiya, H.; Waki, M.; Shimohigashi, Y. 1989: Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection Peptide Research 2(5): 345-351
Andersson, K.E.; Arner, B.; Hedner, P.; Mulder, J.L. 1972: Effects of 8-lysine-vasopressin and synthetic analogues of release of ACTH Acta Endocrinologica 69(4): 640-648
Melin, P.; Akerlund, M.; Vilhardt, H. 1979: Antagonism of the myometrial response to oxytocin and vasopressin by synthetic analogues Danish Medical Bulletin 26(3): 126-128
Helminski, M.; Solecki, R.; Petter, H. 1989: Immunohistochemical studies on pituitary adenomas in Wistar rats. 1. Demonstration of ACTH, LH, neurophysin, oxytocin and vasopressin in the pituitary of Ico:WIST rats from chronic toxicity studies Archiv für Geschwulstforschung 59(6): 433-440
König, W.; Geiger, R.; Wissmann, H.; Bickel, M.; Obermeier, R.; Teetz, W.; Uhmann, R. 1977: Chemical and biological properties of porcine secretin and secretin analogues modified in positions 3 and 4 Gastroenterology 72(4 Pt.2): 797-800
Shibata, M.; Shima, M.; Fujimura, Y.; Takahashi, Y.; Nakai, H.; Sakurai, Y.; Asatani, M.; Nomura, A.; Take, H.; Giddings, J.C.; Yoshioka, A. 1999: Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain Thrombosis and Haemostasis 81(5): 793-798
Rapps, J.A.; Jones, A.W.; Sturek, M.; Magliola, L.; Parker, J.L. 1997: Mechanisms of altered contractile responses to vasopressin and endothelin in canine coronary collateral arteries Circulation 95(1): 231-239
Pozdniakova, T.M.; Rybalchuk, V.N.; Il'ina, A.V.; Davidovich, I.A.; Rogozhin, S.V. 1986: Effect of peptides--structural analogs of NH2-terminal sites of fibrin alpha- and beta-chains--on specific binding of the NH2-terminal disulfide bond of fibrin with fibrinogen Ukrainskii Biokhimicheskii Zhurnal 58(2): 10-15
Afonnikov, D.A.; Kondrakhin, I.V.; Titov, I.I. 1997: Detection of correlating DNA-binding positions in CREB and AP-1 family transcription factors Molekuliarnaia Biologiia 31(4): 741-748
Schück, O.; Cort, J.H.; Stríbrná, J.; Skopková, J.; Jost, K. 1975: A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa Casopis Lekaru Ceskych 114(6): 172-175
Dahl, J.S.; Hellewell, S.B.; Levine, R.P. 1977: A mycoplasma mutant resistant to lysis by C: variations in membrane composition and altered response to the terminal C complex Journal of Immunology 119(4): 1419-1426
Duffy, V.B.; Holler, H.J. 1999: ADA positions: science-based consumer messages. Association Positions Committee Journal of the American Dietetic Association 99(2): 231-233
Savelyeva, M.V.; Baldenkov, G.N.; Kaverina, N.V. 1988: Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues Biomedica Biochimica Acta 47(12): 1085-1087
Moore, G.J.; Kwok, Y.C. 1982: Receptor binding affinities and biological activities of angiotensin analogues in the rat uterus Proceedings of the Western Pharmacology Society 25: 147-149
Lapucci, A.; Macchia, M.; Orlandini, E.; Romagnoli, F.; Rossello, A.; Chiellini, G.; Cozzini, P.; Domiano, P. 1996: (E)-(methyloxyimino)acetamides as analogues of neuroleptic benzamides: synthesis and D2-dopaminergic binding affinity Farmaco 51(1): 33-39
Durette, P.L.; Boger, J.; Dumont, F.; Firestone, R.; Frankshun, R.A.; Koprak, S.L.; Lin, C.S.; Melino, M.R.; Pessolano, A.A.; Pisano, J. 1988: A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine a and analogues Transplantation Proceedings 20(2 Suppl 2: 51-57
Darman, P.S.; Landis, G.C.; Smits, J.R.; Hirning, L.D.; Gulya, K.; Yamamura, H.I.; Burks, T.F.; Hruby, V.J. 1985: Conformationally restricted cyclic analogues of substance P: insight into the receptor binding process Biochemical and Biophysical Research Communications 127(2): 656-662
Jard, S. 1981: Vasopressin isoreceptors in the liver and kidney: relationship between hormone binding and biological response Journal de Physiologie 77(4-5): 621-628